Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: In-hospital and 30-day result of the PAMI stent pilot trial

Journal of the American College of Cardiology

Volumn 31, Issue 1, 1998, Pages 23-30

  Stone, Gregg W ^a   Brodie, Bruce R ^b   Griffin, John J ^c   Morice, Marie Claude ^d   Costantini, Costantino ^e   St Goar, Frederick G ^a   Overlie, Paul A ^f   Popma, Jeffrey J ^g   McDonnell, Joann ^a   Jones, Denise ^h   O'Neill, William W ^h   Grines, Cindy L ^h  

^a EL CAMINO HOSPITAL   (United States)

^b MOSES H CONE MEMORIAL HOSPITAL   (United States)

^c Sentara Virginia Beach General Hospital   (United States)

^d INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

^e Hospital Santa Case de Misericordia   (Brazil)

^f St Mary of the Plains Hospital   (United States)

^g WASHINGTON HOSPITAL CENTER   (United States)

^h WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HEPARIN; TICLOPIDINE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PATIENT SELECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; SAFETY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; FEASIBILITY STUDIES; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PILOT PROJECTS; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; STENTS;

EID: 0031884086     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00439-7     Document Type: Article

References (52)

1. Grines CL, Browne KR, Marco J, et al. A comparison of primary angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 328:1993;673-679.
2. Stone GW, Grines CL, Browne KF, et al. Predictors of in-hospital and 6 month outcome after acute myocardial infarction in the reperfusion era the Primary Angioplasty in Myocardial Infarction (PAMI) trial . J Am Coll Cardiol. 25:1995;370-377.
3. Zijlstra F, DeBoer MJ, Hoorntje JCA, et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 328:1993;680-684.
4. Gibbons RJ, Holmes DR, Reeder GS, et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med. 328:1993;685-691.
5. Michels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative (meta-analysis) of the randomized clinical trials. Circulation. 91:1995;476-485.
6. Stone GW, Grines CL, Browne KF, et al. Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction a comparison of thrombolytic therapy and primary coronary angioplasty . J Am Coll Cardiol. 26:1995;66-72.
7. O'Neill WW, Brodie BR, Ivanhoe R, et al. Primary coronary angioplasty for acute myocardial infarction (the Primary Angioplasty Registry). Am J Cardiol. 73:1994;627-634.
8. Stone GW, Rutherford BD, McConahay DR, et al. Direct coronary angioplasty in acute myocardial infarction outcome in patients with single vessel disease . J Am Coll Cardiol. 15:1990;534-543.
9. Rothbaum DA, Linnemeier TJ, Landin RJ, et al. Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction a 3-year experience . J Am Coll Cardiol. 10:1987;264-272.
10. O'Keefe JH, Bailey WL, Rutherford BD, Hartzler GO. Primary angioplasty for acute myocardial infarction in 1000 consecutive patients. Am J Cardiol. 72:1993;107G-115G.
11. Miller PF, Brodie BR, Weintraub RA, et al. Emergency coronary angioplasty for acute myocardial infarction. Arch Intern Med. 147:1987;1565-1570.
12. Brodie B, Grines CL, Spain M, et al. A prospective, randomized trial evaluating early discharge (day 3) without non-invasive risk stratification in low risk patients with acute myocardial infarction PAMI-2 [abstract] . J Am Coll Cardiol. 25:(Suppl A):1995;5A.
13. Stone GW, Marsalese D, Brodie BR, et al. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol. 29:1997;1459-1467.
14. Ishihara M, Sato H, Tateishi H, Uchida Toshiaki, Dote K. Intraaortic balloon pumping as the post angioplasty strategy in acute myocardial infarction. Am Heart J. 122:1991;385-389.
15. Ohman EM, Califf RM, George BS, et al. The use of intraaortic balloon counterpulsation as an adjunct to reperfusion therapy in acute myocardial infarction. Am Heart J. 191:1991;895-901.
16. Ohman EM, George BS, White CJ, et al., for the Randomized IABP Study Group. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction: results of a randomized trial. Circulation 1994;90:792-9.
17. Ohman EM, Califf RM, Topol EJ, et al. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. Circulation. 82:1990;781-791.
18. O'Neill WW, Weintraub R, Grines CL, et al. A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction. Circulation. 86:1992;1710-1717.
19. Nakae I, Fujita M, Fudo T, et al. Relation between preexistent coronary collateral circulation and the incidence of restenosis after successful primary coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 27:1996;1688-1692.
20. Brodie BR, Grines CL, Ivanhoe R, et al. Six-month clinical and angiographic follow-up after direct angioplasty for acute myocardial infarction. Circulation. 25:1994;156-162.
21. Nakagawa Y, Iwasaki Y, Kimura T, et al. Serial angiographic follow-up after successful direct angioplasty for acute myocardial infarction. Am J Cardiol. 78:1996;980-984.
22. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 331:1994;489-495.
23. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 331:1994;496-501.
24. Versaci F, Gaspardone A, Tomai F, et al. A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending artery. N Engl J Med. 336:1997;817-822.
25. Schatz RA, Baim DS, Leon M, et al. Clinical experience with the Palmaz-Schatz coronary stent initial results of a multicenter trial . Circulation. 83:1991;148-161.
26. Agrawal SK, Ho DSV, Liu MW, et al. Predictors of thrombotic complications after placement of a flexible coil stent. Am J Cardiol. 73:1994;1216-1219.
27. Nakamura S, Colombo A, Gaglione A, et al. Intracoronary ultrasound observations during stent implantation. Circulation. 89:1994;2026-2034.
28. Moussa I, Di Mario C, Di Francesco L, et al. Subacute stent thrombosis and the anticoagulation controversy changes in drug therapy, operator technique, and the impact of intravascular ultrasound . Am J Cardiol. 78:(Suppl 3A):1996;13-17.
29. Gawaz M, Neumann FJ, Ott I, et al. Platelet activation and coronary stent implantation. Effect of antithrombotic therapy. Circulation. 94:1996;279-285.
30. Schomig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med. 334:1996;1084-1089.
31. Leon MB, Baim DS, Gordon P, et al. Clinical and angiographic results form the stent anticoagulation regimen study (STARS) [abstract]. Circulation. 95:(Suppl I):1996;I-685.
32. Mak HK, Belli G, Ellis SG, Moliterno DJ. Subacute stent thrombosis evolving issues and current concepts . J Am Coll Cardiol. 27:1996;494-503.
33. Alfonso F, Rodriguez P, Phillips P, et al. Clinical and angiographic implications of coronary stenting in thrombus-containing lesions. J Am Coll Cardiol. 29:1997;725-733.
34. Piessens JH, Stammen F, Vrolix MC, et al. Effects of an ionic versus a nonionic low osmolar contrast agent of the thrombotic complications of coronary angioplasty. Cathet Cardiovasc Diagn. 28:1993;99-105.
35. Grines CL, Schreiber TL, Savas V, et al. A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 27:1996;1381-1386.
36. Smith AJC, Holt RE, Fitzpatrick K, et al. Transient thrombotic state after abrupt discontinuation of heparin in percutaneous coronary angioplasty. Am Heart J. 131:1996;434-439.
37. The Thrombolysis in Myocardial Infarction (TIMI) trial Phase 1 findings . N Engl J Med. 312:1985;932-936.
38. Popma JJ, Bashore TD. Qualitative and quantitative angiography. Topol E. Textbook of Interventional Cardiology. 1994;1052-1068 W.B. Saunders, Philadelphia.
39. Davies MJ, Thomas AC. Plaque fissuring - the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J. 53:1985;363-373.
40. DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 303:1980;897-902.
41. O'Keefe JH, Rutherford BD, McConahay DR, et al. Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction. Am J Cardiol. 64:1989;1221-1230.
42. Grines C, Brodie B, Griffin J, et al. Which primary PTCA patients may benefit from new technologies? [abstract]. Circulation. 92:(Suppl I):1995;I-146.
43. Benzuly KH, O'Neill WW, Brodie B, et al. Predictors of maintained infarct artery patency after primary angioplasty in high risk patients in PAMI-2 [abstract]. J Am Coll Cardiol. 27:(Suppl A):1996;279A.
44. Stone GW, St. Goar F, Fitzgerald P, et al. The optimal stent implantation trial - final core lab angiographic and ultrasound analysis [abstract]. J Am Coll Cardiol. 29:(Suppl A):1997;369A.
45. Khurana S, Westley S, Maltson JC, Safian RD. Is it possible to expedite the antiplatelet effect of ticlopidine? [abstract]. J Invasive Cardiol. 8:1996;65.
46. Freedman JE, Adelman B. Pharmacology of heparin and oral anticoagulants. Loscalzo J, Schafer AI. Thrombosis and Hemorrhage. 1994;1155-1171 Blackwell Scientific, Boston.
47. Rogers C, Edelman ER. Endovascular stent design dictates experimental restenosis and thrombosis. Circulation. 91:1995;2995-3001.
48. Serruys PW, Emanuelsson HU, van der Giessen W, et al. Heparin-coated Palmaz-Schatz stents in human coronary arteries. Circulation. 93:1996;412-422.
49. Grines CL, Morice MC, Mattos L, et al. A prospective, multicenter trial using the JJIS heparin-coated stent for primary reperfusion of acute myocardial infarction [abstract]. J Am Coll Cardiol. 29:(Suppl A):1997;389A.
50. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med. 330:1994;956-961.
51. Aggarwal RK, Ireland DS, Azrin MA, et al. Antithrombotic potential of polymer-coated stents eluting platelet glycoprotein IIb/IIIa receptor antibody. Circulation. 94:1996;3311-3317.
52. Stone GW, Grines CL, Rothbaum D, et al. Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator the Primary Angioplasty in Myocardial Infarction (PAMI) trial . J Am Coll Cardiol. 29:1997;901-907.